Dow Up 0.35% Nasdaq Down 0.02%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
168.74 Down 1.02(0.60%) 4:00PM EDT
|After Hours : 168.76 Up 0.02 (0.01%) 4:51PM EDT
Prev Close:169.76
Open:168.45
Bid:165.01 x 200
Ask:170.00 x 100
1y Target Est:197.05
Beta:0.51
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:167.55 - 169.91
52wk Range:100.89 - 185.43
Volume:743,918
Avg Vol (3m):1,179,810
Market Cap:33.38B
P/E (ttm):102.02
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNDown 0.60%33.38B
AMGNDown 0.26%100.78B
BAXUp 0.16%40.76B

Key Statistics

Forward P/E (1 yr):29.19
P/S (ttm):17.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback